Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

2018 Cancer Survivorship Symposium: Advancing Care and Research

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).



Related Videos

Survivorship

Lynda M. Beaupin, MD, on Adhering to Follow-up Care: An Analysis

Lynda M. Beaupin, MD, of the Roswell Park Cancer Institute, discusses her findings on the factors contributing to adolescent and young adult cancer survivors not seeking follow-up ...

Geriatric Oncology
Survivorship

Arti Hurria, MD, on Survivorship Care for the Aging Population

Arti Hurria, MD, of the City of Hope, discusses ways to incorporate the principles of geriatrics into oncology care and offer targeted interventions for older survivors.

Survivorship

Paul B. Jacobsen, PhD, on The Impact of Survivorship Care Plans: Expert Perspective

Paul B. Jacobsen, PhD, of the National Cancer Institute, discusses his evaluation of whether survivorship care plans have a positive impact on health outcomes and health-care deliv...

Survivorship

Patricia A. Ganz, MD, on Progress in Cancer Survivorship Care

Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her ...

Survivorship

Carrie R. Howell, PhD, on Reducing Risks for Childhood Cancer Survivors: Trial Results

Carrie R. Howell, PhD, of St. Jude Children’s Research Hospital, discusses study findings on a web-based exercise intervention for adolescent survivors, who are at increased risk f...

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.